| Literature DB >> 24272516 |
A Kumar1, S K Mukerjee, S K Bhattacharya.
Abstract
Thirty-three N (3)-2-, -3- or -4-substituted aryl-N (1)-(alkyl/aryl/substituted aryl)-triazene N (1)-oxides were synthesized and evaluated for their anticonvulsant and monoamine oxidase (MAO) inhibitory activities. Most of the compounds exhibited MAO inhibitory activity in vitro, and kinetic studies conducted with N (3)-4-chlorophenyl-N (1)-methyltriazene N (1)-oxide, the most potent inhibitor, showed that the inhibition is non-competitive in nature. The MAO inhibiting activity of the compounds correlated well with their anticonvulsant effect against maximal electroshock-induced seizures in rats. Acute toxicity studies indicate that the compounds have a wide margin of safety.Entities:
Year: 1985 PMID: 24272516 DOI: 10.1023/A:1016374224529
Source DB: PubMed Journal: Pharm Res ISSN: 0724-8741 Impact factor: 4.200